aptio group Denmark ApS
Core data
Name | aptio group Denmark ApS |
Address | Krakasvej 17 1, 3400, Hillerød |
Founded | Mar 12, 2018 |
| 55 / 50 | |
Locations (P-units) | 1View locations |
Website | https://aptiogroup.com/dk/ |
Branch | Virksomhedsrådgivning og anden ledelsesrådgivning (702000) |
Name | aptio group Denmark ApS |
Address | Krakasvej 17 1, 3400, Hillerød |
Founded | Mar 12, 2018 |
| 55 / 50 |
Locations (P-units) | 1View locations |
Website | https://aptiogroup.com/dk/ |
Branch | Virksomhedsrådgivning og anden ledelsesrådgivning (702000) |
Keep track of aptio group Denmark ApS
Description
Aptio Group Denmark is a consultancy company focused on the pharmaceutical industry, providing specialized expertise and support for pharmaceutical manufacturing challenges.
Provides specialized pharmaceutical consulting, from regulatory support to full-scale project execution, to improve the efficiency, safety, and efficacy of pharma manufacturing.
Company's own description on virk.dk
Aptio Group er en konsulentvirksomhed med specialisering inden for den farmaceutiske, bioteknologiske og medicotekniske sektor. Selskabet leverer højt specialiserede konsulentydelser inden for en række kerneområder, herunder Quality & Compliance, Engineering, Medical Devices, Project Management, Tech Transfer samt beslægtede ydelser. Med et team af erfarne og fagligt funderede konsulenter tilbyder virksomheden ekspertbistand, der understøtter kundernes behov i et reguleret og teknisk komplekst marked. Virksomhedens erklærede mission er at levere konsulentydelser af høj kvalitet og med stor faglig dybde, hvilket bidrager til værdiskabelse og driftssikkerhed hos kunderne i den farmaceutiske og beslægtede industri.
Products & services
Pharmaceutical consulting · Regulatory support · Full-scale project execution · Engineering expertise · Medical device expertise · Manufacturing sciences and tech transfer · Fill and finish engineering
Industries
Pharmaceutical consulting · Pharmaceutical manufacturing · Life sciences · Medical devices
Customer types
Pharmaceutical companies · Life science companies
Financials
| Reporting period | 2025DKK | |||||||
|---|---|---|---|---|---|---|---|---|
| Gross profit | 88,454,105 | |||||||
| Profit before tax | 19,001,041 | |||||||
| Net income | 14,765,799 | |||||||
| Total assets | 94,554,357 | |||||||
| Equity | 30,484,900 | |||||||
| Avg. employees | 47 | |||||||
2018–2025 Unlock financial history | ||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Dan Erik Juncker | Roles BoardManagement | TitlesBESTYRELSESMEDLEM • ADM. DIR. |
| Lars Bo Ousted Olsen | Roles Board | TitlesSUPPLEANT |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Beierholm | AuditorMichael Krath | RoleStatsaut. revisor | FromJul 6, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
Foreign legal entity | Ownership66.67–89.99 % | Voting rights66.67 % | FromJan 24, 2020 |
| Ownership10–14.99 % | Voting rights10 % | FromJan 1, 2020 | |
| Ownership10–14.99 % | Voting rights10 % | FromJan 24, 2020 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| 🇸🇪Aptio Group Sweden AB | Ownership through Direct | 66.67–89.99 % |
| Dan Erik Juncker | Ownership through | 10–14.99 % |
| Lars Bo Ousted Olsen | Ownership through | 10–14.99 % |